Your browser doesn't support javascript.
loading
Harnessing hyaluronic acid-based nanoparticles for combination therapy: A novel approach for suppressing systemic inflammation and to promote antitumor macrophage polarization.
Rangasami, Vignesh K; Samanta, Sumanta; Parihar, Vijay Singh; Asawa, Kenta; Zhu, Keying; Varghese, Oommen P; Teramura, Yuji; Nilsson, Bo; Hilborn, Jöns; Harris, Robert A; Oommen, Oommen P.
Afiliação
  • Rangasami VK; Bioengineering and Nanomedicine Lab, Faculty of Medicine and Health Technologies, Tampere University and BioMediTech Institute, 33720, Tampere, Finland. Electronic address: vignesh.rangasami@tuni.fi.
  • Samanta S; Bioengineering and Nanomedicine Lab, Faculty of Medicine and Health Technologies, Tampere University and BioMediTech Institute, 33720, Tampere, Finland. Electronic address: sumanta.samanta@tuni.fi.
  • Parihar VS; Bioengineering and Nanomedicine Lab, Faculty of Medicine and Health Technologies, Tampere University and BioMediTech Institute, 33720, Tampere, Finland. Electronic address: vijay.parihar@tuni.fi.
  • Asawa K; Department of Bioengineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan. Electronic address: asawa@celly.t.u-tokyo.ac.jp.
  • Zhu K; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Centre for Molecular Medicine, Karolinska University Hospital, 171 76, Solna, Stockholm, Sweden. Electronic address: keying.zhu@ki.se.
  • Varghese OP; Bioengineering and Nanomedicine Lab, Faculty of Medicine and Health Technologies, Tampere University and BioMediTech Institute, 33720, Tampere, Finland. Electronic address: oommen.varghese@kemi.uu.se.
  • Teramura Y; Department of Bioengineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75105, Sweden. Electronic address: teramura@bioeng.t.u-tokyo.ac.jp.
  • Nilsson B; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75105, Sweden. Electronic address: bo.nilsson@igp.uu.se.
  • Hilborn J; Translational Chemical Biology Laboratory, Department of Chemistry, Ångström Laboratory, Uppsala University, 751 21, Uppsala, Sweden. Electronic address: jons.hilborn@kemi.uu.se.
  • Harris RA; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Centre for Molecular Medicine, Karolinska University Hospital, 171 76, Solna, Stockholm, Sweden. Electronic address: Robert.harris@ki.se.
  • Oommen OP; Bioengineering and Nanomedicine Lab, Faculty of Medicine and Health Technologies, Tampere University and BioMediTech Institute, 33720, Tampere, Finland. Electronic address: oommen.oommen@tuni.fi.
Carbohydr Polym ; 254: 117291, 2021 Feb 15.
Article em En | MEDLINE | ID: mdl-33357860
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Portadores de Fármacos / Doxorrubicina / Polaridade Celular / Nanopartículas / Ácido Hialurônico / Macrófagos / Anti-Inflamatórios / Antibióticos Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Carbohydr Polym Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Portadores de Fármacos / Doxorrubicina / Polaridade Celular / Nanopartículas / Ácido Hialurônico / Macrófagos / Anti-Inflamatórios / Antibióticos Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Carbohydr Polym Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido